Previous close | 472.80 |
Open | 474.70 |
Bid | 480.00 x 0 |
Ask | 480.30 x 0 |
Day's range | 473.40 - 481.60 |
52-week range | 308.60 - 559.40 |
Volume | |
Avg. volume | 204,343 |
Market cap | 34.623B |
Beta (5Y monthly) | 0.63 |
PE ratio (TTM) | 54.00 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 4.00 (0.85%) |
Ex-dividend date | 13 May 2024 |
1y target est | N/A |
Explore key insights from Acumen Pharmaceuticals' Q1 2024 earnings, focusing on their innovative Alzheimer's treatments and financial outlook.
Despite a net loss, MRVI showcases strategic expansions and robust partnerships, setting the stage for future growth.
Lonza Group ( VTX:LONN ) Full Year 2023 Results Key Financial Results Revenue: CHF6.72b (up 7.9% from FY 2022). Net...